CN111481633A - Traditional Chinese medicine composition for treating neurasthenia and insomnia - Google Patents

Traditional Chinese medicine composition for treating neurasthenia and insomnia Download PDF

Info

Publication number
CN111481633A
CN111481633A CN202010463895.8A CN202010463895A CN111481633A CN 111481633 A CN111481633 A CN 111481633A CN 202010463895 A CN202010463895 A CN 202010463895A CN 111481633 A CN111481633 A CN 111481633A
Authority
CN
China
Prior art keywords
parts
insomnia
traditional chinese
chinese medicine
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010463895.8A
Other languages
Chinese (zh)
Inventor
仲崇允
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010463895.8A priority Critical patent/CN111481633A/en
Publication of CN111481633A publication Critical patent/CN111481633A/en
Priority to CN202110568034.0A priority patent/CN113304227A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/09—Lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating neurasthenia and insomnia, which is prepared from the following raw material medicines in parts by weight: 1.5-3 parts of lotus plumule and schisandra chinensis; 3-9 parts of moldavica dragonhead and gastrodia elata; 6-12 parts of dogbane leaves; 10-20 parts by weight of Taibai tea, acanthopanax and lucid ganoderma; and 15-30 parts by weight of dancing grass, radix pseudostellariae and nostoc commune.

Description

Traditional Chinese medicine composition for treating neurasthenia and insomnia
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine for treating neurasthenia and insomnia.
Background
Neurasthenia is a type of neurosis mainly characterized by a weakened brain and body function. It is characterized by easy excitation and fatigue, and is often accompanied by emotional symptoms such as tension, vexation and easy irritation, and physiological dysfunction symptoms such as muscle tension pain and sleep disorder. These symptoms are not secondary to somatic diseases and organic lesions of the brain, nor are they part of any other mental disorder. There may be persistent emotional stress and mental stress in the patient before illness. The western medicine mainly uses oryzanol tablets or anxiolytic and antidepressant drugs to treat neurasthenia, can improve anxiety and depression of patients, also can relax muscles and eliminate body discomfort.
The understanding of insomnia by clinical medicine science is limited at present, but clinical doctors begin to define insomnia according to clinical research, and a sleep disorder department of the neurology conference of the Chinese medical society in 2012 sets up a Chinese adult insomnia diagnosis and treatment guideline according to the existing evidence of evidence, wherein insomnia refers to subjective experience of patients on the condition that sleep time and/or quality are not satisfied and daily social functions are affected.
At present, no specific medicine for treating neurasthenia and insomnia exists.
Disclosure of Invention
The invention aims to improve the defects of the prior art and provide the traditional Chinese medicine composition for treating neurasthenia and insomnia, can effectively improve or even eliminate clinical symptoms of patients, and has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.
Neurasthenia belongs to the categories of depression, insomnia, palpitation and the like in traditional Chinese medicine. Is a neurological disease with various clinical symptoms caused by brain dysfunction due to the long-term overstrain, heavy mental burden or mental trauma of patients. The pathogenesis of this disease is mostly caused by seven emotions with internal injuries, especially the relationship with long-term mental depression, excessive anxiety and mental stress is the most closely related. Emotional internal injury often causes disharmony of qi, blood, yin and yang of the zang-fu organs, thereby causing a series of clinical symptoms. Therefore, it has the actions of soothing liver, purging fire, clearing phlegm-heat, nourishing yin, lowering fire, tonifying heart and spleen, nourishing heart, tranquilizing mind and harmonizing heart and kidney. The body of the human body is regulated on the whole so as to achieve the aim of thorough healing.
Based on the theory, the invention provides a traditional Chinese medicine for treating neurasthenia and insomnia, which is prepared from the following raw material medicines in parts by weight: 1.5-3 parts of lotus plumule and schisandra chinensis; 3-9 parts of moldavica dragonhead and gastrodia elata; 6-12 parts of dogbane leaves; 10-20 parts by weight of Taibai tea, acanthopanax and lucid ganoderma; and 15-30 parts by weight of dancing grass, radix pseudostellariae and nostoc commune.
In a preferred embodiment, the traditional Chinese medicine composition for treating neurasthenia and insomnia consists of the following raw material medicines in parts by weight: lotus plumule and schisandra fruit 3 weight portions; 9 parts of moldavica dragonhead and rhizoma gastrodiae; 12 parts of dogbane leaf; taibai tea, acanthopanax root and ganoderma lucidum 20 weight portions; 30 parts of dancing grass, heterophylly falsestarwort root and gynura divaricata.
Wherein, the dogbane leaf: sweet, bitter and cool. It enters liver meridian. Pacify liver, tranquilize mind, clear heat and induce diuresis. Can be used for treating vertigo due to liver-yang, neurasthenia, palpitation, insomnia due to liver-fire disturbing heart, and hypertension.
Lotus plumule with bitter taste; is cold. Returning to the heart; a lung; the kidney channel. Clearing away heart fire; calming liver fire, stopping bleeding; to arrest spontaneous emission. Can be used for treating vexation and insomnia due to liver fire disturbing heart.
Gastrodia elata: sweet and neutral. It enters liver meridian. Pacify liver, extinguish wind and stop spasm. Can be used for treating headache, vertigo, vexation, insomnia, and neurasthenia due to liver fire disturbing heart. Gastrodine (gastrodine) has effective rates of 89.44% and 86.87% for treating neurasthenia and neurasthenia syndrome. It can also inhibit central excitation caused by caffeine, and enhance sleep time effect of pentobarbital. Gastrodia elata has the functions of improving eyesight and obviously enhancing memory. The gastrodia elata has obvious protection and regulation effects on the brain nervous system of a human.
Radix pseudostellariae: sweet, slightly bitter and neutral. It enters spleen and lung meridians. To replenish qi, invigorate the spleen, promote the production of body fluid and moisten the lung. Can be used for treating spleen deficiency, asthenia, and weakness of spleen and stomach; neurasthenia, palpitation, insomnia, dizziness and amnesia due to deficiency of both heart and spleen.
Acanthopanax root: pungent, slightly bitter and warm. It enters spleen, kidney and heart meridians. The functions are mainly used for replenishing qi to invigorate the spleen, tonifying the kidney and soothing the nerves. It is especially effective in treating yang deficiency of spleen and kidney, asthenia, debilitation, anorexia, soreness of waist and knees, and insomnia and dreaminess due to deficiency of both heart and spleen.
Schisandra chinensis: sour, sweet and warm. It enters lung, heart and kidney meridians. Astringe to arrest discharge, benefit qi and promote the production of body fluid, tonify kidney and calm heart. Can be used for treating spontaneous perspiration, night sweat, thirst due to body fluid consumption, shortness of breath, weak pulse, internal heat, diabetes, palpitation, and insomnia due to disharmony between heart and kidney.
Taibai tea: sweet; bitter; diluting; cooling; entering the lung; the stomach; a core; the liver meridian. Clearing heat and promoting fluid production; refreshing and tranquilizing. Can be used for treating vexation, thirst, neurasthenia, insomnia due to hyperactivity of fire due to yin deficiency, hectic fever due to yin deficiency, hypertension, etc.
Ganoderma lucidum: sweet in taste; flattening; is nontoxic. Entering the lung; a core; a spleen; the kidney channel. Replenishing qi and blood; calming the heart; invigorating spleen and stomach. Can be used for treating neurasthenia, insomnia, amnesia, anorexia, tiredness, short breath, and hyperhidrosis; dizziness; mental fatigue, debilitation, etc.
And (3) bean vermicelli dish: sweet and mild in taste. Moisten lung to arrest cough, nourish heart to calm mind, remove food retention and expel ascaris. Can be used for treating bronchitis, neurasthenia, etc.
And (3) fragrant blue: pungent, bitter and cool. Clear lung-heat, relieve exterior syndrome, cool liver and stop bleeding. Can be used for treating tracheitis, asthma, heart disease, neurasthenia, etc.
Dancing grass: slightly astringent and flat. Tranquilizing, removing blood stasis, promoting tissue regeneration, promoting blood circulation, and relieving swelling. It is indicated for neurasthenia due to blood stasis blocking collaterals.
The invention is prepared from Chinese traditional herbal medicines, and the traditional Chinese medicine for effectively treating neurasthenia and insomnia is formed by orderly matching certain natural extracts with definite components and clear effects according to a plurality of principles of traditional Chinese medicine treatment based on syndrome differentiation and modern medicine.
The invention can be used throughout the whole process of treating neurasthenia and insomnia, treats both symptoms and root causes, is not easy to relapse, is safe and reliable, has no obvious toxic and side effects, is convenient for patients to insist on taking for a long time, has no adverse reaction for the patients after taking the medicine for many years, and tracks the blood examination to be normal.
The traditional Chinese medicine composition has the advantages of easily available raw materials, simple process, low cost and high efficiency, and is beneficial to pharmaceutical enterprises for medicine production and quality control; the product has low price and is easy to be accepted by patients.
The traditional Chinese medicine composition has remarkable treatment effect on neurasthenia and insomnia, and clinical experiment results show that the traditional Chinese medicine composition is used for treating neurasthenia and insomnia, one dose of the traditional Chinese medicine composition is taken every day, the traditional Chinese medicine composition is decocted with 100 ml of water and divided into two parts, the medicine composition is taken one part in the morning and at night, one part is taken one month as a treatment course, the effect is achieved in one treatment course, the three treatment courses are obviously improved, and the functions of the six treatment courses are basically cured. The cure rate is 88 percent, and the total effective rate is 100 percent.
The invention also provides an oral preparation prepared from the traditional Chinese medicine composition for treating neurasthenia and insomnia, the oral preparation comprises oral liquid, tablets, capsules, pills and the like, preferably the dosage forms are tablets and capsules, and one dose is taken every day in the morning and at night.
The traditional Chinese medicine composition can be prepared into various dosage forms. For example, the decocted liquid medicine is sterilized and disinfected and then packaged to prepare oral liquid; or concentrating the decoction, oven drying, adding pharmaceutically acceptable adjuvants, and making into tablet, capsule, pill, etc.
The medically acceptable auxiliary materials comprise starch, dextrin, sodium carboxymethylcellulose, polyethylene glycol, calcium hydrophosphate, sodium alginate, potassium sorbate and the like.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention in any way, and it will be apparent to those skilled in the art that the above description of the present invention can be applied to various modifications, equivalent variations or modifications without departing from the spirit and scope of the present invention.

Claims (4)

1. The traditional Chinese medicine for treating neurasthenia and insomnia is characterized by comprising the following raw material medicines in parts by weight: 1.5-3 parts of lotus plumule and schisandra chinensis; 3-9 parts of moldavica dragonhead and gastrodia elata; 6-12 parts of dogbane leaves; 10-20 parts by weight of Taibai tea, acanthopanax and lucid ganoderma; and 15-30 parts by weight of dancing grass, radix pseudostellariae and nostoc commune.
2. The traditional Chinese medicine for treating neurasthenia and insomnia as claimed in claim 1, which is characterized by comprising the following raw material medicines in parts by weight: lotus plumule and schisandra fruit 3 weight portions; 9 parts of moldavica dragonhead and rhizoma gastrodiae; 12 parts of dogbane leaf; taibai tea, acanthopanax root and ganoderma lucidum 20 weight portions; 30 parts of dancing grass, heterophylly falsestarwort root and gynura divaricata.
3. An oral preparation for treating neurasthenia and insomnia, which is characterized by being prepared from the traditional Chinese medicine composition as claimed in any one of claims 1 or 2.
4. The oral preparation for treating neurasthenia and insomnia according to claim 3, which is characterized by comprising oral liquid, tablets, capsules and pills, preferably oral liquid and tablets.
CN202010463895.8A 2020-05-28 2020-05-28 Traditional Chinese medicine composition for treating neurasthenia and insomnia Pending CN111481633A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202010463895.8A CN111481633A (en) 2020-05-28 2020-05-28 Traditional Chinese medicine composition for treating neurasthenia and insomnia
CN202110568034.0A CN113304227A (en) 2020-05-28 2021-05-25 Traditional Chinese medicine composition for treating neurasthenia and insomnia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010463895.8A CN111481633A (en) 2020-05-28 2020-05-28 Traditional Chinese medicine composition for treating neurasthenia and insomnia

Publications (1)

Publication Number Publication Date
CN111481633A true CN111481633A (en) 2020-08-04

Family

ID=71790860

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202010463895.8A Pending CN111481633A (en) 2020-05-28 2020-05-28 Traditional Chinese medicine composition for treating neurasthenia and insomnia
CN202110568034.0A Pending CN113304227A (en) 2020-05-28 2021-05-25 Traditional Chinese medicine composition for treating neurasthenia and insomnia

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202110568034.0A Pending CN113304227A (en) 2020-05-28 2021-05-25 Traditional Chinese medicine composition for treating neurasthenia and insomnia

Country Status (1)

Country Link
CN (2) CN111481633A (en)

Also Published As

Publication number Publication date
CN113304227A (en) 2021-08-27

Similar Documents

Publication Publication Date Title
CN102687773A (en) Liver-nourishing health tea
CN110585331A (en) Mulberry sleep-aiding paste and preparation method thereof
CN104825801A (en) TCM (traditional Chinese medicine) preparation for preventing and treating cardiovascular and cerebrovascular diseases
CN105255637B (en) A kind of health preserving wine and its brew method
CN104083438A (en) Balsam pear-containing traditional Chinese medicinal preparation for alleviating hypertension, and preparation method thereof
CN100490883C (en) Drug of gastrodia elata for invigorating brain
CN103751591A (en) Preparation method of traditional Chinese medicine for treating hyperlipemia caused by deficiency of both yin and yang
CN104474428B (en) A kind of Chinese medicine preparation and preparation method for the treatment of spinal cord injury
CN111481633A (en) Traditional Chinese medicine composition for treating neurasthenia and insomnia
CN102670948A (en) Winter pear fruit dew for moistening lung, relieving asthma and relieving cough and preparation method thereof
CN105878627A (en) Traditional Chinese medicine formula for treating myopic disease
CN102048956A (en) Medicinal liquor
CN111617153A (en) Traditional Chinese medicine composition for tonifying consumptive disease and strengthening primordial yang and preparation and application thereof
CN112915148A (en) A Chinese medicinal composition for treating sexual impotence, premature ejaculation and sexual disorder
CN109091634A (en) A kind of health liquor for treating pain, rheumatism and traumatic injury
CN104688855B (en) A kind of Chinese goldthread colla corii asini composition for treating chronic fatigue syndrome and its application
CN109432336A (en) A kind of Uygur medicine herbal-composition and preparation method thereof for treating bronchial asthma
CN115645451B (en) Tibet bath composition, tibetan bath medicament, preparation method and use method
CN113786470B (en) Traditional Chinese medicine composition for treating deficiency of both qi and blood, food containing traditional Chinese medicine composition and preparation method
CN107349395A (en) For treating neurasthenic Chinese medicine preparation
CN113876836A (en) A topical Chinese medicinal composition for foot bath for children, and its preparation method
CN104784588A (en) Traditional Chinese medicine preparation for treating nerve headache and preparation method
CN103356984B (en) Traditional Chinese medicine composition for preventing and treating female iron deficiency anemia
CN104383245A (en) Traditional Chinese medicine mixture for treating yin deficiency and yang excess type insomnia
CN103751678A (en) Preparation method of traditional Chinese medicine for treating spleen/kidney-yang-deficiency-type hyperlipemia

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200804

WD01 Invention patent application deemed withdrawn after publication